Citations

Showing 10 of 108083 citations.

Response by Brinjikji et al to Letter Regarding Article, “Anesthesia-Related Outcomes for Stroke Revascularization: A Systematic Review and Meta-Analysis”
Brinjikji, Waleed , Murad, M. Hassan , Murad, Mohammad H, Murad, M Hassan , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | December 8, 2017 | Volume: 49 | Issue: 1 | Pages: No page available

10.1161/strokeaha.117.019656 | PMID 29222228 Get It

Impact of a Shared Decision Making Intervention on Health Care Utilization: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial
Schaffer, Jason T. , Kline, Jeffrey A. , Diercks, Deborah B. , Jones, Russell, Demers, Michel, Inselman, Jonathan , Shah, Nilay D. , Torres, Carlos A, Hess, Erik P. , Hollander, Judd E. , Torres, Carlos A., Owen, Kelly P. , Meisel, Zachary F. , LeBlanc, Annie , Herrin, Jeph , Montori, Víctor M.

Mayo Clinic

Academic Emergency Medicine | December 8, 2017 | Volume: 25 | Issue: 3 | Pages: 293-300

10.1111/acem.13355 | PMID 29218817 Get It

AbstractBackgroundPatients at low risk for acute coronary syndrome are frequently admitted for observation and cardiac testing, resulting in substantial burden and cost to the patient and the health care system.ObjectivesThe purpose of this investigation was to measure the effect of the Chest Pain Choice (CPC) decision aid on overall health care utilization as well as utilization of specific services both during the index emergency department (ED) visit and in the subsequent 45 days.MethodsThis was a planned secondary analysis of data from a pragmatic multicenter randomized trial of shared decision making in adults presenting to the ED with chest pain who were being considered for observation unit admission for cardiac stress testing or coronary computed tomography angiography. The trial compared an intervention group engaged in shared decision making facilitated by the CPC decision aid to a control group receiving usual care. Hospital‐level billing data were used to measure utilization for the index ED visit and during the following 45 days. Patients in both groups also were asked to keep a diary recording health care utilization over the same 45‐day period. Outcomes assessed included length of time in the ED and observation, ED visits, office visits, hospitalizations, testing, imaging, and procedures.ResultsOf the 898 patients included in the original trial, we were able to contact 834 (92.9%) patients for 45‐day health care diary review. There was no difference in patient‐reported health care utilization between the study arms. Hospital‐level billing data were obtained for all 898 (100%) patients. During the initial ED visit the length of stay (LOS) was similar, and there was no difference in the frequency of observation unit admission between study arms. However, the mean observation unit LOS was 95 minutes (95% confidence interval [CI] = 40.8–149.8) shorter in the CPC arm and the mean number of tests was lower in the CPC arm (decrease in 19.4 imaging studies per 100 patients, 95% CI = 15.5–23.3). When evaluating the entire encounter and follow‐up period, the intervention arm underwent fewer tests (decrease in 125.6 tests per 100 patients, 95% CI = 29.3–221.6). More specifically, there were fewer advanced cardiac imaging tests completed (25.8 fewer per 100 patients, 95% CI = 3.74–47.9) in the intervention arm.ConclusionsShared decision making in low‐risk chest pain can lead to decreased diagnostic testing without worsening outcomes measured over 45 days.
The Rho(ad)-kinase for individualized treatment of vasospastic angina
Lerman, Lilach O. , Widmer, R. Jay , Lerman, Amir

Mayo Clinic

European Heart Journal | December 8, 2017 | Volume: 39 | Issue: 11 | Pages: 960-962

10.1093/eurheartj/ehx757 | PMID 29293909 Get It

Pediatric Disorders of Orthostatic Intolerance
Stewart, Julian M. , Boris, Jeffrey R. , Chelimsky, Gisela , Fischer, Phillip R., Fortunato, John E. , Jarjour, Imad T. , Medow, Marvin S. , Numan, Mohammed T. , Tarbell, Sally E. , Chelimsky, Thomas , Society, The Pediatric Writing Group of the American Autonomic, Pianosi, Paolo T. , Grubb, Blair P. , Heyer, Geoffrey L. , Singer, Wolfgang , Society, The Pediatric Writing Group of the American Autonomic

Mayo Clinic

Pediatrics | December 8, 2017 | Volume: 141 | Issue: 1 | Pages: No page available

10.1542/peds.2017-1673 | PMID 29222399 Get It

Orthostatic intolerance (OI), having difficulty tolerating an upright posture because of symptoms or signs that abate when returned to supine, is common in pediatrics. For example, ∼40% of people faint during their lives, half of whom faint during adolescence, and the peak age for first faint is 15 years. Because of this, we describe the most common forms of OI in pediatrics and distinguish between chronic and acute OI. These common forms of OI include initial orthostatic hypotension (which is a frequently seen benign condition in youngsters), true orthostatic hypotension (both neurogenic and nonneurogenic), vasovagal syncope, and postural tachycardia syndrome. We also describe the influences of chronic bed rest and rapid weight loss as aggravating factors and causes of OI. Presenting signs and symptoms are discussed as well as patient evaluation and testing modalities. Putative causes of OI, such as gravitational and exercise deconditioning, immune-mediated disease, mast cell activation, and central hypovolemia, are described as well as frequent comorbidities, such as joint hypermobility, anxiety, and gastrointestinal issues. The medical management of OI is considered, which includes both nonpharmacologic and pharmacologic approaches. Finally, we discuss the prognosis and long-term implications of OI and indicate future directions for research and patient management.
Regulation of Lipolytic Response and Energy Balance by Melanocortin 2 Receptor Accessory Protein (MRAP) in Adipocytes
Zhang, Xiaodong , Saarinen, Alicia M., Campbell, Latoya E., Filippis, Elena A. De, Liu, Jun , De Filippis, Elena A, Liu, Jun

Mayo Clinic

Diabetes | December 8, 2017 | Volume: 67 | Issue: 2 | Pages: 222-234

10.2337/db17-0862 | PMID 29217655 Get It

Melanocortin 2 receptor accessory protein (MRAP) is highly expressed in adrenal gland and adipose tissue. In adrenal cells, MRAP is essential for adrenocorticotropic hormone (ACTH)–induced activation of the cAMP/protein kinase A (PKA) pathway by melanocortin 2 receptor (MC2R), leading to glucocorticoid production and secretion. Although ACTH was known to stimulate PKA-dependent lipolysis, the functional involvement of MRAP in adipocyte metabolism remains incompletely defined. Herein, we found that knockdown or overexpression of MRAP in 3T3-L1 adipocytes reduced or increased ACTH-induced lipolysis, respectively. Moreover, an unbiased proteomics screen and coimmunoprecipitation analysis identified Gαs as a novel interacting partner of MRAP. An MRAP mutant disabled in Gαs association failed to augment the activation of PKA and lipolytic response to ACTH. Furthermore, compared with wild-type mice, transgenic mice (aP2-MRAP) overexpressing MRAP fat specifically exhibited increased lipolytic response to ACTH. When fed a high-fat diet (HFD), the transgenic mice displayed a significant decrease in the gain of adiposity and body weight as well as an improvement in glucose and insulin tolerance. These phenotypes were accompanied by increased adipose expression of genes for mitochondrial fatty acid oxidation and thermogenesis, and overall energy expenditure. Collectively, our data strongly suggest that MRAP plays a critical role in the regulation of ACTH-induced adipose lipolysis and whole-body energy balance.
Human perforin gene variation is geographically distributed
Willenbring, Robin, Ikeda, Yasuhiro , Pease, Larry R. , Johnson, Aaron J. , Orozco, Robin C. , Willenbring, Robin C , Johnson, Aaron J.

Mayo Clinic

Molecular Genetics & Genomic Medicine | December 7, 2017 | Volume: 6 | Issue: 1 | Pages: 44-55

10.1002/mgg3.344 | PMID 29216683 Get It

AbstractBackgroundDeleterious mutations in PRF1 result in lethal, childhood disease, familial hemophagocytic lymphohistiocytosis type 2 (FHL 2). However, not all mutations in PRF1 are deleterious and result in FHL 2. Currently, these nondeleterious mutations are being investigated in the onset of numerous disorders, such as lymphomas and diabetes. Yet, there is still an overwhelmingly large amount of PRF1 mutations that are not associated with disease.MethodsWe conducted a post hoc analysis of the PRF1 mutations in the coding region using the recently published Exome Aggregation Consortium genomes, Leiden Open Variation Database, NCBI SNP database, and primary literature to better understand PRF1 variation in the human population.ResultsThis study catalogs 460 PRF1 mutations in the coding region, and demonstrates PRF1 is more variant then previously predicted. We identify key PRF1 mutations with high allelic frequency and are only found in certain populations. Additionally, we define PRF1 SNVs are geographically distributed.ConclusionsThis study concludes with a novel hypothesis that nondeleterious mutation in PRF1, which decreases perforin expression and/or activity, may be an example of selective advantage in the context of environmental stressors prevalent near the equator. Our studies illustrate how perforin deficiency can be protective from injuries resulting in blood–brain barrier (BBB) disruption.
New and incremental FDA black box warnings from 2008 to 2015
Solotke, Michael T. , Dhruva, Sanket S. , Downing, Nicholas S., Shah, Nilay D. , Ross, Joseph S. , Ross, Joseph S

Mayo Clinic

Expert Opinion on Drug Safety | December 7, 2017 | Volume: 17 | Issue: 2 | Pages: 117-123

10.1080/14740338.2018.1415323 | PMID 29215916 Get It

Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis
Bae, Taejeong , Tomasini, Livia , Mariani, Jessica , Zhou, Bo , Roychowdhury, Tanmoy , Franjic, Daniel , Pletikos, Mihovil , Pattni, Reenal , Chen, Bo-Juen , Venturini, Elisa , Riley‐Gillis, Bridget , Šestan, Nenad , Urban, Alexander E. , Abyzov, Alexej , Vaccarino, Flora M. , Zhou, Bo , Vaccarino, Flora M , Abyzov, Alexej , Bae, Taejeong

Mayo Clinic

Science | December 7, 2017 | Volume: 359 | Issue: 6375 | Pages: 550-555

10.1126/science.aan8690 | PMID 29217587 Get It

Brain mutations, young and old Most neurons that make up the human brain are postmitotic, living and functioning for a very long time without renewal (see the Perspective by Lee). Bae et al. examined the genomes of single neurons from the prenatal developing human brain. Both the type of mutation and the rates of accumulation changed between gastrulation and neurogenesis. These early mutations could be generating useful neuronal diversity or could predispose individuals to later dysfunction. Lodato et al. also found that neurons take on somatic mutations as they age by sequencing single neurons from subjects aged 4 months to 82 years. Somatic mutations accumulated with increasing age and accumulated faster in individuals affected by inborn errors in DNA repair. Postmitotic mutations might only affect one neuron, but the accumulated divergence of genomes across the brain could affect function. Science , this issue p. 550 , p. 555 ; see also p. 521
PHIP- a novel candidate breast cancer susceptibility locus on 6q14.1
Jiao, Xiang , Collaborators, NBCS, Investigators, kConFab/AOCS, Aravidis, Christos , Marikkannu, Rajeshwari, Rantala, Johanna, Adamović, Tatjana , Maguire, Paula , Kremeyer, Bárbara , Holst, Susanna von, Kontham, Vinaykumar, Thutkawkorapin, Jessada , Margolin, Sara , Du, Quan , Lundin, Johanna , Michailidou, Kyriaki , Bolla, Manjeet K. , Wang, Qin , Andrulis, Irene L. , Antonenkova, Natalia, Beckmann, Matthias W. , Blomqvist, Carl , Blot, William J. , Bojesen, Stig E. , Brand, Judith S. , Brauch, Hiltrud , Brenner, Hermann , Brüning, Thomas , Burwinkel, Barbara , Chang‐Claude, Jenny , Couch, Fergus J. , Deming-Halverson, Sandra, Dörk, Thilo , Eriksson, Mikael , Fasching, Peter A. , Figueroa, Jonine D. , Flesch‐Janys, Dieter, Flyger, Henrik, Gabrielson, Marike , García‐Closas, Montserrat , González‐Neira, Anna , Guénel, Pascal , Guo, Qi , Gündert, Melanie , Haiman, Christopher A., Hallberg, Emily, Hamann, Ute , Harrington, Patricia, Hooning, Maartje J. , Hopper, John L. , Huang, Guanmengqian, Jakubowska, Anna , Jones, Michael E. , Kerin, Michael J. , Kosma, Veli‐Matti , Kristensen, Vessela N. , Lambrechts, Diether , Lubiński, Jan , Mannermaa, Arto, Meindl, Alfons, Mulligan, Anna Marie , Peto, Julian, Pylkäs, Katri , Radice, Paolo , Rhenius, Valerie , Sawyer, Elinor J. , Schmutzler, Rita K., Seynaeve, Caroline, Shah, Mitul , Simard, Jacques , Southey, Melissa C. , Swerdlow, Anthony J. , Truong, Thérèse , Wendt, Camilla, Winqvist, Robert , Easton, Douglas F. , Lindblom, Annika , Durocher, Francine , Bowtell, David D.L. , Lambrechts, Diether , Dörk, Thilo , Lambrechts, Diether , Swerdlow, Anthony J , Radice, Paolo , Southey, Melissa C , Jakubowska, Anna , Jones, Michael E , Lambrechts, Diether , Brenner, Hermann , Guénel, Pascal , García-Closas, Montserrat , Michailidou, Kyriaki , Simard, Jacques , Eriksson, Mikael , Figueroa, Jonine D , Gabrielson, Marike , Bowtell, David D , Collaborators, NBCS, Investigators, kConFab/AOCS, Picelli, Simone , Liu, Tao , Luo, Liping , Dennis, Joe , Lush, Michael J. , Ambrosone, Christine B. , Anton‐Culver, Hoda , Arndt, Volker , Boeckx, Bram , Bonanni, Bernardo , Broeks, Annegien , Cai, Qiuyin , Couch, Fergus J. , Cox, Angela , Cross, Simon S. , Devilee, Peter , dos‐Santos‐Silva, Isabel , Giles, Graham G. , Hooning, Maartje J. , Marchand, Loı̈c Le , Mannermaa, Arto, Martens, John W.M. , Meindl, Alfons, Milne, Roger L. , Neuhausen, Susan L. , Nevanlinna, Heli , Schmidt, Marjanka K. , Zheng, Wei , Benı́tez, Javier , Dunning, Alison M. , Pharoah, Paul D.P. , Czene, Kamila , Hall, Per N , Pylkäs, Katri , Lubinski, Jan , Bojesen, Stig E , Truong, Therese , Brauch, Hiltrud , Lindblom, Annika , Sawyer, Elinor J

Mayo Clinic

Oncotarget | December 7, 2017 | Volume: 8 | Issue: 61 | Pages: 102769-102782

10.18632/oncotarget.21800 | PMID 29262523 Get It

Multivariate generalized linear model for genetic pleiotropy
Schaid, Daniel J. , Tong, Xingwei, Batzler, Anthony , Sinnwell, Jason P. , Sinnwell, Jason P , Jiang, Qing Yan , Biernacka, Joanna M.

Mayo Clinic

Biostatistics | December 7, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/biostatistics/kxx067 | PMID 29267957 Get It